SCHEMBL31111448

SCHEMBL31111448

C#CCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GAA P10253 1/20 0.43
CA12 O43570 5/20 0.41
CA1 P00915 5/20 0.41
CA2 P00918 5/20 0.41
CA9 Q16790 5/20 0.41
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
IDO1 P14902 1/20 0.39
BCHE P06276 1/20 0.39
CNR2 P34972 1/20 0.39
EPHX1 P07099 1/20 0.38
ADRB2 P07550 1/20 0.38
HTR1A P08908 1/20 0.38
TSHR P16473 1/20 0.38
SUCNR1 Q9BXA5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22276586 1.00 TDP1 (0.45) TDP1MEN1KMT2AGAACA12
SCHEMBL19451386 1.00 TDP1 (0.45) TDP1MEN1KMT2AGAACA12
SCHEMBL20840280 1.00 TDP1 (0.45) TDP1MEN1KMT2AGAACA12
SCHEMBL13759230 1.00 TDP1 (0.45) TDP1MEN1KMT2AGAACA12
SCHEMBL30484826 1.00 TDP1 (0.45) TDP1MEN1KMT2AGAACA12
SCHEMBL612182 0.97 TDP1 (0.47) TDP1MEN1KMT2AGAACA12
SCHEMBL25721633 0.96 TDP1 (0.42) TDP1MEN1KMT2AGAACA12
SCHEMBL22796847 0.94 TDP1 (0.46) TDP1MEN1KMT2AGAACA12
SCHEMBL23789774 0.92 TDP1 (0.39) TDP1MEN1KMT2AGAACA12
SCHEMBL23662963 0.92 TDP1 (0.39) TDP1MEN1KMT2AGAACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673424-A1 LIQUID PHASE PEPTIDE SUPPORT SYNTHESIS OF PEPTIDES AND PEPTIDOMIMETICS Regeneron Pharmaceuticals, Inc. (US) 2026-01-07 EP disclosed
WO-2024182268-A1 LIQUID PHASE PEPTIDE SUPPORT SYNTHESIS OF PEPTIDES AND PEPTIDOMIMETICS REGENERON PHARMACEUTICALS, INC. (US) 2024-09-06 WO disclosed